Evidence map›Paper›PMID 25762214›Full record

ArticleTissue engineering. Part A2015

Development of poly(ethylene glycol) hydrogels for salivary gland tissue engineering applications.

Andrew D Shubin, Timothy J Felong, Dean Graunke, Catherine E Ovitt, Danielle S W Benoit

Abstract read
In one paragraph

Article in Tissue engineering. Part A, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Salivary Gland Bioengineering.Bioengineering (Basel, Switzerland) · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andrew D Shubin1Department of Biomedical Engineering, University of Rochester, Rochester, New York.
Timothy J Felong1Department of Biomedical Engineering, University of Rochester, Rochester, New York.
Dean Graunke1Department of Biomedical Engineering, University of Rochester, Rochester, New York.
Catherine E Ovitt2Center for Oral Biology, University of Rochester, Rochester, New York.
Danielle S W Benoit1Department of Biomedical Engineering, University of Rochester, Rochester, New York.

Funding

Translating PTH Therapy as an Adjuvant for Structural AllograftingP50AR054041 · NIAMS · UNIVERSITY OF ROCHESTER · PI SCHWARZ, EDWARD M. · 2006 to 2016
$15.7M
University of Rochester Mentoring Environment: Nurturing Training Opportunities in Research (UR-MENTOR)T32GM007356 · NIGMS · UNIVERSITY OF ROCHESTER · PI O'BANION, M. KERRY · 1985 to 2023
$15.1M
The University of Rochester Core Center for Musculoskeletal Biology and MedicineP30AR061307 · NIAMS · UNIVERSITY OF ROCHESTER · PI SCHWARZ, EDWARD M. · 2011 to 2015
$3.0M
Cell Based Regeneration of Salivary GlandsR01DE022949 · NIDCR · UNIVERSITY OF ROCHESTER · PI OVITT, CATHERINE · 2012 to 2015
$1.5M
Olympus NanoZoomer RS Whole Slide Imaging SystemS10RR027340 · NCRR · UNIVERSITY OF ROCHESTER · PI BOYCE, BRENDAN F · 2010 to 2010
$340k
Polyethylene glycol Hydrogels for Salivary Gland RegenerationF30CA183320 · NCI · UNIVERSITY OF ROCHESTER · PI SHUBIN, ANDREW DEAN · 2015 to 2018
$96k
NCI NIH HHS F30 CA183320NCI NIH HHS F30CA183320NIAMS NIH HHS P30 AR061307NIAMS NIH HHS P50 AR054041NIDCR NIH HHS R01 DE022949NIGMS NIH HHS T32 GM7356
6 · The paper itself

Abstract

More than 40,000 patients are diagnosed with head and neck cancers annually in the United States with the vast majority receiving radiation therapy. Salivary glands are irreparably damaged by radiation therapy resulting in xerostomia, which severely affects patient quality of life. Cell-based therapies have shown some promise in mouse models of radiation-induced xerostomia, but they suffer from insufficient and inconsistent gland regeneration and accompanying secretory function. To aid in the development of regenerative therapies, poly(ethylene glycol) hydrogels were investigated for the encapsulation of primary submandibular gland (SMG) cells for tissue engineering applications. Different methods of hydrogel formation and cell preparation were examined to identify cytocompatible encapsulation conditions for SMG cells. Cell viability was much higher after thiol-ene polymerizations compared with conventional methacrylate polymerizations due to reduced membrane peroxidation and intracellular reactive oxygen species formation. In addition, the formation of multicellular microspheres before encapsulation maximized cell-cell contacts and increased viability of SMG cells over 14-day culture periods. Thiol-ene hydrogel-encapsulated microspheres also promoted SMG proliferation. Lineage tracing was employed to determine the cellular composition of hydrogel-encapsulated microspheres using markers for acinar (Mist1) and duct (Keratin5) cells. Our findings indicate that both acinar and duct cell phenotypes are present throughout the 14 day culture period. However, the acinar:duct cell ratios are reduced over time, likely due to duct cell proliferation. Altogether, permissive encapsulation methods for primary SMG cells have been identified that promote cell viability, proliferation, and maintenance of differentiated salivary gland cell phenotypes, which allows for translation of this approach for salivary gland tissue engineering applications.

Indexed as

Amino Acid SequenceAnimalsCell DifferentiationCell SurvivalCell TransplantationCollagenFemaleHydrogelsLipid PeroxidationMethacrylatesMiceMice, Inbred C57BLMicrospheresMolecular StructureOxidative StressPeptidesCollagenHydrogelsMethacrylatesPeptidespolyethylene glycol methacrylatePolyethylene GlycolsReactive Oxygen SpeciesSulfhydryl Compounds

Identifiers

PMID25762214
PMCPMC4449707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.